Stake logo

AVNS

Avanos Medical, Inc.

About AVNS

Avanos Medical, Inc. is a medical technology company, which focused on delivering medical device solutions. The Company develops, manufactures and markets solutions in approximately 90 countries. It provides a portfolio of product offerings focused on chronic care and pain management to improve patient outcomes. Chronic care is a portfolio of products, which include digestive health products, such as its Mic-Key enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as its closed airway suction systems and other airway management devices under the Ballard, Microcuff and Endoclear brands. Pain management is a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and Interventional pain solutions, which provides pain relieving therapies, such as its Coolief pain therapy.

Buy US stocks in Australia starting with AVNS. Open an account and start investing today!

Market Capitalisation

$1.44B

Price-earnings ratio

-

Dividend yield

0.00%

Volume

104.84K

High today

$31.47

Low today

$30.56

Open price

$30.80

52-week high

$35.76

52-week low

$19.32


AVNS FAQs

One share of Avanos Medical, Inc. is valued at $31.41.

The ticker symbol for Avanos Medical, Inc. is AVNS.

To buy AVNS stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:
  1. Sign up in minutes, all you need is some I.D.
  2. Choose Stake Wall St
  3. Deposit directly into your Stake wallet and you're ready to invest in AVNS

As of 07/02/2023 Avanos Medical, Inc. has a market cap of $1.4B.

The Avanos Medical, Inc. 52-week high stock price is $35.76.

The Avanos Medical, Inc. 52-week low stock price is $19.32.


Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.